An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ages 65 to 74.

Researchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a ...

Antimicrobial resistance (AMR) is predicted to cause 10 million deaths every year by 2050. Since its identification more than 50 years ago, pleuromutilin has served as a scaffold for the development ...

Among asthma patients infected with COVID-19, those who received the antiviral drug nirmatrelvir-ritonavir (Paxlovid) had ...

It's recommended to avoid drinking large amounts of grapefruit juice while taking buspirone. Norvir (ritonavir) is a protease inhibitor used to treat human immunodeficiency virus (HIV) and also be ...

Antiretroviral drugs are used to treat HIV infection. They work by blocking a stage of the virus's life cycle and, by doing so, prevent the virus from replicating. The drugs are organized into six ...

The following drugs are CYP3A inhibitors: cobicistat (Tybost) ritonavir (Norvir) Cobicistat cannot promote anti-HIV activity when it’s used alone, so it’s always paired with another ...

Background: Nirmatrelvir-ritonavir is an oral treatment for SARS-CoV-2 infection in patients who are at high risk of developing severe COVID-19 disease. This antiviral has proven to significantly ...

This study investigated the dissociation processes of ritonavir unbinding from HIV protease (HIVp). Analyzing unbinding trajectories modeled by accelerated molecular dynamics (MD) simulations, three ...